We looked into the effect of thymoquinone on the NF-κβ signalling pathway in the AMD model of ARPE-19 cells to determine if thymoquinone is able to decrease the activation of the NF-κβ signalling pathway in ARPE-19 cells and, hence, reduce inflammatory reactions. Here, NFKB1 is linked to age-related macular degeneration.